Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Potassium channel antagonist improves motor function in model of stroke

Feb. 10, 2012

Eribulin mesilate added to chemotherapy in patients with bladder cancer

Feb. 10, 2012

Polypeptide confers neuroprotection after stroke

Feb. 10, 2012

New stem cell therapy improves stroke outcome in preclinical models

Feb. 9, 2012

Detailed results presented of phase III regorafenib study

Feb. 9, 2012

Carbon nanomaterials display antioxidant characteristics

Feb. 9, 2012

Japanese study compares drugs to retard symptom progression after stroke

Feb. 9, 2012

Bradykinin B1 receptor antagonist reduces pain in vivo

Feb. 8, 2012

New phase I safety data presented on stroke therapy

Feb. 8, 2012

Foretinib shows promise in large papillary renal cell carcinoma study

Feb. 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...